Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Delivered a solid Q1 2025 outperforming expectations, driven by Pharma segment performance. Organizational restructuring is...
— David Herro
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Bayer
No other institutional pitches found for this ticker yet.
More institutional theses from Harris Associates International Equity Strategy